Related Experiment Video
Updated: Jan 11, 2026
07:15
Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
851
Autophagy in the Pathogenesis of Membranous Nephropathy
Claudio Ponticelli1, Francesco Reggiani2,3, Gabriella Moroni2,3
1Independent investigator, Milan, Italy.
Kidney Medicine
|November 10, 2025
Summary
Membranous nephropathy (MN) involves immune attacks on podocytes. Autophagy, a cellular process, plays a complex role in MN, potentially driving autoantibody production but also offering podocyte protection and influencing disease progression.
Area of Science:
- Nephrology
- Immunology
- Cell Biology
Background:
- Membranous nephropathy (MN) is a primary cause of nephrotic syndrome in adults, often idiopathic.
- Antibodies against podocyte proteins, like the M-type phospholipase A2 receptor, are implicated in MN pathogenesis.
- Autophagy, a cellular degradation process, has a potentially dual role in MN.
Purpose of the Study:
- To explore the mechanisms regulating macroautophagy in the context of MN.
- To examine the specific role of autophagy in the pathogenesis and progression of MN.
- To discuss the therapeutic potential of modulating autophagy in MN.
Main Methods:
- Review of current literature on autophagy mechanisms and MN.
- Analysis of the dual role of autophagy in immune response and podocyte injury.
- Exploration of preliminary studies on autophagy modulation for MN treatment.
Main Results:
- Autophagy can influence immune responses, potentially promoting autoantibody production against podocyte antigens.
- Autophagy also confers protective effects on podocytes, mitigating apoptosis and injury.
- Autophagy is involved in the progression of tubulointerstitial fibrosis, contributing to chronic kidney disease.
Conclusions:
- Autophagy has a complex, context-dependent role in membranous nephropathy.
- Understanding autophagy regulation is crucial for developing novel therapeutic strategies for MN.
- Targeting autophagy may offer a promising avenue for treating MN and preventing kidney failure.
Related Concept Videos
01:27Autophagy
5.6K
Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
5.6K
01:36Delivery Pathways to the Lysosome
8.7K
Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
8.7K
01:18Autophagic Cell Death
4.3K
Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
4.3K
01:22Lysosomal Hydrolases
4.4K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.4K
01:13The Proteasome
1.6K
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
1.6K
02:18The Proteasome
10.0K
Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
10.0K